print
email
   
   
Investors > Financials by Segment
Segment wise revenue, results, assets, liabilities and capital employed
for the quarter and year ended 30 June, 2017
Rs.In Lacs
  Quarter ended
  Unaudited
30 June
Unaudited
30 June
 
2017
2016

1. Segment revenue

   

  a) Pharmaceuticals

16,093 14,369

  b) Crop protection products

10,577 8,227

Total

26,670 22,596

Less: Inter segment revenue

- -

 Net sales / income from operation

26,670 22,596

2. Segment results

   

Profit before interest & tax

   

  a) Pharmaceuticals

2,459 1,829

  b) Crop protection products

957 1,254

Total

3,416               3,083

Less :

   

  i) Finance cost

1,169 1,321
  ii) Other un-allocable expenditure 544 464
Add :    

  i) Other un-allocable income

127                     56

  Profit before tax

1,830 1,354
     

3. Segment assets

   

 a) Pharmaceuticals

87,159 87,300

 b) Crop protection products

44,589 35,659

 c) Unallocated

12,758 12,066

Total segment assets

144,506 135,025
     

4. Segment liabilities

   

 a) Pharmaceuticals

19,098 15,404

 b) Crop protection products

10,901 6,645

 c) Unallocated

52,633 56,820

Total segment liabilities

82,632 78,869
     

5. Capital employed

   

 a) Pharmaceuticals

68,061 71,896

 b) Crop protection products

33,688 29,014

 c) Unallocated

              (39,875)             (44,754)

Total capital employed

61,874 56,156